Page last updated: 2024-10-26

domperidone and Aprosodia

domperidone has been researched along with Aprosodia in 1 studies

Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.

Research Excerpts

ExcerptRelevanceReference
"Those ascribed to gastroesophageal reflux and vocal abuse have a high resolution rate, although some cases need rescue procedures."1.30Clinical evolution of laryngeal granulomas: treatment and prognosis. ( De Biase, NG; de Lima Pontes, PA; Gadelha, EC, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Lima Pontes, PA1
De Biase, NG1
Gadelha, EC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Controlled Trial Comparing Proton Pump Inhibitor Therapy With and Without Interarytenoid Botulinum Toxin Injection for Vocal Fold Granuloma[NCT01678053]Phase 20 participants (Actual)Interventional2012-09-30Withdrawn (stopped due to Was not able to recruit patients for randomization.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for domperidone and Aprosodia

ArticleYear
Clinical evolution of laryngeal granulomas: treatment and prognosis.
    The Laryngoscope, 1999, Volume: 109, Issue:2 Pt 1

    Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antiemetics; Botulinum Toxins, Type A; Combined Modality

1999